BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10526207)

  • 1. A genetic program for deletion of foreign DNA from the mammalian genome.
    Scrable H; Stambrook PJ
    Mutat Res; 1999 Oct; 429(2):225-37. PubMed ID: 10526207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the lac repressor in the transgenic mouse.
    Scrable H; Stambrook PJ
    Genetics; 1997 Sep; 147(1):297-304. PubMed ID: 9286689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of CpG dinucleotides in the lacI gene of the Big Blue transgenic mouse.
    You YH; Halangoda A; Buettner V; Hill K; Sommer S; Pfeifer G
    Mutat Res; 1998 Dec; 420(1-3):55-65. PubMed ID: 9838042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of a new mutation model for active genes: expression of the Escherichia coli lac operon in mammalian cells.
    van Sloun PP; Lohman PH; Vrieling H
    Mutat Res; 1997 Sep; 382(1-2):21-33. PubMed ID: 9360635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lacI transgenic mutation-detection system and its application to establish baseline mutation frequencies in the scid mouse.
    Andrew SE; Pownall S; Fox J; Hsiao L; Hambleton J; Penney JE; Kohler SW; Jirik FR
    Mutat Res; 1996 Oct; 357(1-2):57-66. PubMed ID: 8876680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice.
    Skopek T; Marino D; Kort K; Miller J; Trumbauer M; Gopal S; Chen H
    Mutat Res; 1998 May; 400(1-2):77-88. PubMed ID: 9685590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A novel bifunctional in vivo mutation detection system].
    Yao ZZ; Li HX; Che WL; He Y; Fu JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):199-203. PubMed ID: 12006996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals.
    Wyborski DL; DuCoeur LC; Short JM
    Environ Mol Mutagen; 1996; 28(4):447-58. PubMed ID: 8991077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA; Buettner VL; Glickman BW; Sommer SS
    Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
    Davies R; Gant TW; Smith LL; Styles JA
    Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of mutational spectra from different genes: analyses of PhIP-induced mutational specificity in the lacI and cII transgenes from colon of Big Blue rats.
    Stuart GR; Thorleifson E; Okochi E; de Boer JG; Ushijima T; Nagao M; Glickman BW
    Mutat Res; 2000 Jul; 452(1):101-21. PubMed ID: 10894896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mutant frequency and altered mutation spectrum of the lacI transgene in Wilson disease rats with hepatitis.
    Sone H; Li YJ; Ishizuka M; Aoki Y; Nagao M
    Cancer Res; 2000 Sep; 60(18):5080-6. PubMed ID: 11016632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting somatic mutation frequencies in vivo.
    Zhang XB; Urlando C; Tao KS; Heddle JA
    Mutat Res; 1995 Oct; 338(1-6):189-201. PubMed ID: 7565874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
    You YH; Pfeifer GP
    J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the origin of unusual mutations recovered from the lacI transgenic assay.
    de Boer JG
    Mutat Res; 2003 Apr; 536(1-2):1-6. PubMed ID: 12694740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous mutations in lacI-containing lambda lysogens derived from transgenic mice: the observed patterns differ in liver and spleen.
    Knöll A; Jacobson DP; Kretz PL; Lundberg KS; Short JM; Sommer SS
    Mutat Res; 1994 Nov; 311(1):57-67. PubMed ID: 7526175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.